Short term outcomes of COVID-19 in lupus: Propensity score matched analysis from a nationwide multi-centric research network
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Short term outcomes of COVID-19 in lupus: Propensity score matched analysis from a nationwide multi-centric research network
Authors
Keywords
SLE, SARS CoV-2, Nephritis, Immunosuppressants
Journal
JOURNAL OF AUTOIMMUNITY
Volume 125, Issue -, Pages 102730
Publisher
Elsevier BV
Online
2021-10-12
DOI
10.1016/j.jaut.2021.102730
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical outcomes of COVID-19 in patients with rheumatic diseases: A systematic review and meta-analysis of global data
- (2021) Chuanhui Xu et al. AUTOIMMUNITY REVIEWS
- Coronavirus disease 2019, immune-mediated inflammatory diseases and immunosuppressive therapies – A Danish population-based cohort study
- (2021) Mohamed Attauabi et al. JOURNAL OF AUTOIMMUNITY
- Risk and clinical outcomes of COVID-19 in patients with rheumatic diseases compared with the general population: a systematic review and meta-analysis
- (2021) Qingxiu Wang et al. RHEUMATOLOGY INTERNATIONAL
- Predictive factors for a severe course of COVID‐19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival
- (2021) Michala Jakubíková et al. EUROPEAN JOURNAL OF NEUROLOGY
- Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets
- (2021) Jon Hazeldine et al. Frontiers in Immunology
- Outcomes of COVID-19 in patients with rheumatoid arthritis: A multicenter research network study in the United States
- (2021) Rahul Raiker et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- The plight of patients with lupus nephritis in Wuhan, China
- (2020) Cheng Chen et al. JOURNAL OF RHEUMATOLOGY
- Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study
- (2020) Jose L Pablos et al. ANNALS OF THE RHEUMATIC DISEASES
- Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow’s triad
- (2020) Sakir Ahmed et al. CLINICAL RHEUMATOLOGY
- Factors associated with COVID-19-related death using OpenSAFELY
- (2020) Elizabeth J. Williamson et al. NATURE
- Leveraging the United States Epicenter to Provide Insights on COVID‐19 in Patients with Systemic Lupus Erythematosus
- (2020) Ruth Fernandez‐Ruiz et al. Arthritis & Rheumatology
- Coronavirus Disease 2019 Case Surveillance — United States, January 22–May 30, 2020
- (2020) Erin K. Stokes et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Impact of Obesity on Outcomes of Patients with COVID-19 in United States: A Multicenter Electronic Health Records Network Study.
- (2020) Shailendra Singh et al. GASTROENTEROLOGY
- Predictors of mortality in patients with COVID-19 – a systematic review
- (2020) Esmaeil Mehraeen et al. European Journal of Integrative Medicine
- Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis
- (2020) Stephanie L. Harrison et al. PLOS MEDICINE
- Evolution of COVID-19 in patients with autoimmune rheumatic diseases
- (2020) Rongrong Pang et al. Aging-US
- Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients
- (2020) ANNALS OF THE RHEUMATIC DISEASES
- Interferon Alpha as a Primary Pathogenic Factor in Human Lupus
- (2011) Timothy B. Niewold JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: Results from an analysis of data from a US claims database
- (2010) Elise M. Pelletier et al. CLINICAL THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now